| Financial Year |
March 31 2023 |
| Monetary Funds |
544,073,473.39 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,312,229,599.44 |
| Advances to Suppliers |
127,023,131.25 |
| Other Receivables |
11,543,994.35 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
297,179,070.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
146,605,549.73 |
| Total Current Assets |
2,574,654,818.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
512,104,395.64 |
| Investment Properties |
8,601,157.90 |
| Fixed Assetes |
14,608,004,242.09 |
| Under-construction Projects |
114,982,708.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
241,445,293.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,618,043.99 |
| Deferred Income Tax Assets |
145,611,403.78 |
| Other Non-Current Assets |
155,538,110.15 |
| Sub-Total of Non-Current Assets |
15,821,503,320.99 |
| Total Assets |
18,396,158,139.28 |
| Short-Term Loans |
8,841,189,965.43 |
| Trading Financial liabilities |
-- |
| Notes Payable |
403,756,315.35 |
| Accounts Payable |
717,329,434.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
30,427,553.02 |
| Taxes Payable |
35,516,500.53 |
| Interest Payable |
-- |
| Dividend Payable |
357,330.02 |
| Other payables |
240,263,197.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,930,649,409.83 |
| Other Current Liabilities |
1,101,603.40 |
| Sub-Total of Current Liabilities |
12,226,508,245.56 |
| Long-term Loans |
6,091,976,699.03 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,175,966,700.51 |
| Special Payable |
-- |
| Estimatied Liabilities |
23,637,890.41 |
| Deferred Income Tax Liabilities |
31,233,841.75 |
| Other Non-Current Liabilities |
93,788,825.15 |
| Sub-Total of Non-Current Liabilities |
8,562,099,038.83 |
| Total Liabilities |
20,788,607,284.39 |
| Paid-In Capital(Or Share Stock) |
1,472,706,817.00 |
| Capital Surplus |
1,369,860,499.19 |
| Surplus Reserve |
136,729,413.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,028,200,799.22 |
| Minority Stockholder's Interest |
-352,749,119.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-2,039,700,025.31 |
| Owner's Equity（Stockholder's Equity） |
-2,392,449,145.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,396,158,139.28 |
